Report Detail
Global Complement C5 Recombinant Monoclonal Antibody Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4735957 |
- 24 August, 2026 |
- Global |
- 74 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Complement C5 Recombinant Monoclonal Antibody market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Complement C5 recombinant monoclonal antibody is a biologic drug designed to specifically target and block complement protein C5, which is a critical component of the immune system’s complement pathway.This class of drugs is used to treat diseases caused by excessive complement activation, such as paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and neuromyelitis optica spectrum disorder (NMOSD).
This report is a detailed and comprehensive analysis for global Complement C5 Recombinant Monoclonal Antibody market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Complement C5 Recombinant Monoclonal Antibody market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Complement C5 Recombinant Monoclonal Antibody market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Complement C5 Recombinant Monoclonal Antibody market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Complement C5 Recombinant Monoclonal Antibody market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Complement C5 Recombinant Monoclonal Antibody
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Complement C5 Recombinant Monoclonal Antibody market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Regeneron Pharmaceuticals, Alexion Pharmaceuticals, Amgen, Samsung Bioepis, Roche, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Complement C5 Recombinant Monoclonal Antibody market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Crovalimab
Ravulizumab
Eculizumab
Pozelimab
Others
Market segment by Application
PNH
aHUS
CD55 Deficiency
Others
Major players covered
Regeneron Pharmaceuticals
Alexion Pharmaceuticals
Amgen
Samsung Bioepis
Roche
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Complement C5 Recombinant Monoclonal Antibody product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Complement C5 Recombinant Monoclonal Antibody, with price, sales quantity, revenue, and global market share of Complement C5 Recombinant Monoclonal Antibody from 2021 to 2026.
Chapter 3, the Complement C5 Recombinant Monoclonal Antibody competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Complement C5 Recombinant Monoclonal Antibody breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Complement C5 Recombinant Monoclonal Antibody market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Complement C5 Recombinant Monoclonal Antibody.
Chapter 14 and 15, to describe Complement C5 Recombinant Monoclonal Antibody sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Complement C5 Recombinant Monoclonal Antibody Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Crovalimab
- 1.3.3 Ravulizumab
- 1.3.4 Eculizumab
- 1.3.5 Pozelimab
- 1.3.6 Others
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Complement C5 Recombinant Monoclonal Antibody Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 PNH
- 1.4.3 aHUS
- 1.4.4 CD55 Deficiency
- 1.4.5 Others
- 1.5 Global Complement C5 Recombinant Monoclonal Antibody Market Size & Forecast
- 1.5.1 Global Complement C5 Recombinant Monoclonal Antibody Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Complement C5 Recombinant Monoclonal Antibody Sales Quantity (2021-2032)
- 1.5.3 Global Complement C5 Recombinant Monoclonal Antibody Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Regeneron Pharmaceuticals
- 2.1.1 Regeneron Pharmaceuticals Details
- 2.1.2 Regeneron Pharmaceuticals Major Business
- 2.1.3 Regeneron Pharmaceuticals Complement C5 Recombinant Monoclonal Antibody Product and Services
- 2.1.4 Regeneron Pharmaceuticals Complement C5 Recombinant Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Regeneron Pharmaceuticals Recent Developments/Updates
- 2.2 Alexion Pharmaceuticals
- 2.2.1 Alexion Pharmaceuticals Details
- 2.2.2 Alexion Pharmaceuticals Major Business
- 2.2.3 Alexion Pharmaceuticals Complement C5 Recombinant Monoclonal Antibody Product and Services
- 2.2.4 Alexion Pharmaceuticals Complement C5 Recombinant Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Alexion Pharmaceuticals Recent Developments/Updates
- 2.3 Amgen
- 2.3.1 Amgen Details
- 2.3.2 Amgen Major Business
- 2.3.3 Amgen Complement C5 Recombinant Monoclonal Antibody Product and Services
- 2.3.4 Amgen Complement C5 Recombinant Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Amgen Recent Developments/Updates
- 2.4 Samsung Bioepis
- 2.4.1 Samsung Bioepis Details
- 2.4.2 Samsung Bioepis Major Business
- 2.4.3 Samsung Bioepis Complement C5 Recombinant Monoclonal Antibody Product and Services
- 2.4.4 Samsung Bioepis Complement C5 Recombinant Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Samsung Bioepis Recent Developments/Updates
- 2.5 Roche
- 2.5.1 Roche Details
- 2.5.2 Roche Major Business
- 2.5.3 Roche Complement C5 Recombinant Monoclonal Antibody Product and Services
- 2.5.4 Roche Complement C5 Recombinant Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Roche Recent Developments/Updates
3 Competitive Environment: Complement C5 Recombinant Monoclonal Antibody by Manufacturer
- 3.1 Global Complement C5 Recombinant Monoclonal Antibody Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Complement C5 Recombinant Monoclonal Antibody Revenue by Manufacturer (2021-2026)
- 3.3 Global Complement C5 Recombinant Monoclonal Antibody Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Complement C5 Recombinant Monoclonal Antibody by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Complement C5 Recombinant Monoclonal Antibody Manufacturer Market Share in 2025
- 3.4.3 Top 6 Complement C5 Recombinant Monoclonal Antibody Manufacturer Market Share in 2025
- 3.5 Complement C5 Recombinant Monoclonal Antibody Market: Overall Company Footprint Analysis
- 3.5.1 Complement C5 Recombinant Monoclonal Antibody Market: Region Footprint
- 3.5.2 Complement C5 Recombinant Monoclonal Antibody Market: Company Product Type Footprint
- 3.5.3 Complement C5 Recombinant Monoclonal Antibody Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Complement C5 Recombinant Monoclonal Antibody Market Size by Region
- 4.1.1 Global Complement C5 Recombinant Monoclonal Antibody Sales Quantity by Region (2021-2032)
- 4.1.2 Global Complement C5 Recombinant Monoclonal Antibody Consumption Value by Region (2021-2032)
- 4.1.3 Global Complement C5 Recombinant Monoclonal Antibody Average Price by Region (2021-2032)
- 4.2 North America Complement C5 Recombinant Monoclonal Antibody Consumption Value (2021-2032)
- 4.3 Europe Complement C5 Recombinant Monoclonal Antibody Consumption Value (2021-2032)
- 4.4 Asia-Pacific Complement C5 Recombinant Monoclonal Antibody Consumption Value (2021-2032)
- 4.5 South America Complement C5 Recombinant Monoclonal Antibody Consumption Value (2021-2032)
- 4.6 Middle East & Africa Complement C5 Recombinant Monoclonal Antibody Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Complement C5 Recombinant Monoclonal Antibody Sales Quantity by Type (2021-2032)
- 5.2 Global Complement C5 Recombinant Monoclonal Antibody Consumption Value by Type (2021-2032)
- 5.3 Global Complement C5 Recombinant Monoclonal Antibody Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Complement C5 Recombinant Monoclonal Antibody Sales Quantity by Application (2021-2032)
- 6.2 Global Complement C5 Recombinant Monoclonal Antibody Consumption Value by Application (2021-2032)
- 6.3 Global Complement C5 Recombinant Monoclonal Antibody Average Price by Application (2021-2032)
7 North America
- 7.1 North America Complement C5 Recombinant Monoclonal Antibody Sales Quantity by Type (2021-2032)
- 7.2 North America Complement C5 Recombinant Monoclonal Antibody Sales Quantity by Application (2021-2032)
- 7.3 North America Complement C5 Recombinant Monoclonal Antibody Market Size by Country
- 7.3.1 North America Complement C5 Recombinant Monoclonal Antibody Sales Quantity by Country (2021-2032)
- 7.3.2 North America Complement C5 Recombinant Monoclonal Antibody Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Complement C5 Recombinant Monoclonal Antibody Sales Quantity by Type (2021-2032)
- 8.2 Europe Complement C5 Recombinant Monoclonal Antibody Sales Quantity by Application (2021-2032)
- 8.3 Europe Complement C5 Recombinant Monoclonal Antibody Market Size by Country
- 8.3.1 Europe Complement C5 Recombinant Monoclonal Antibody Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Complement C5 Recombinant Monoclonal Antibody Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Complement C5 Recombinant Monoclonal Antibody Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Complement C5 Recombinant Monoclonal Antibody Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Complement C5 Recombinant Monoclonal Antibody Market Size by Region
- 9.3.1 Asia-Pacific Complement C5 Recombinant Monoclonal Antibody Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Complement C5 Recombinant Monoclonal Antibody Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Complement C5 Recombinant Monoclonal Antibody Sales Quantity by Type (2021-2032)
- 10.2 South America Complement C5 Recombinant Monoclonal Antibody Sales Quantity by Application (2021-2032)
- 10.3 South America Complement C5 Recombinant Monoclonal Antibody Market Size by Country
- 10.3.1 South America Complement C5 Recombinant Monoclonal Antibody Sales Quantity by Country (2021-2032)
- 10.3.2 South America Complement C5 Recombinant Monoclonal Antibody Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Complement C5 Recombinant Monoclonal Antibody Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Complement C5 Recombinant Monoclonal Antibody Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Complement C5 Recombinant Monoclonal Antibody Market Size by Country
- 11.3.1 Middle East & Africa Complement C5 Recombinant Monoclonal Antibody Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Complement C5 Recombinant Monoclonal Antibody Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Complement C5 Recombinant Monoclonal Antibody Market Drivers
- 12.2 Complement C5 Recombinant Monoclonal Antibody Market Restraints
- 12.3 Complement C5 Recombinant Monoclonal Antibody Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Complement C5 Recombinant Monoclonal Antibody and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Complement C5 Recombinant Monoclonal Antibody
- 13.3 Complement C5 Recombinant Monoclonal Antibody Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Complement C5 Recombinant Monoclonal Antibody Typical Distributors
- 14.3 Complement C5 Recombinant Monoclonal Antibody Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Complement C5 Recombinant Monoclonal Antibody. Industry analysis & Market Report on Complement C5 Recombinant Monoclonal Antibody is a syndicated market report, published as Global Complement C5 Recombinant Monoclonal Antibody Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Complement C5 Recombinant Monoclonal Antibody market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
